13F HOLDINGS REPORT
Merck & Co., Inc.
Quarter ended Q3 2025 · Filed November 12, 2025 · Accession 0000310158-25-000063
Total Value
$228.0M
Positions
13
Other Managers
1
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PERSONALIS INC | PSNL | 14,044,943 | $91.6M | 40.16% |
| 2 | MODERNA INC | MRNA | 2,308,190 | $59.6M | 26.15% |
| 3 | KYMERA THERAPEUTICS INC | KYMR | 772,165 | $43.7M | 19.17% |
| 4 | ALECTOR INC | ALEC | 3,545,719 | $10.5M | 4.60% |
| 5 | ENTRADA THERAPEUTICS INC | TRDA | 1,739,768 | $10.1M | 4.43% |
| 6 | EVAXION BIOTECH A/S | 29970R204 | 1,214,126 | $4.6M | 2.00% |
| 7 | SUTRO BIOPHARMA INC | STRO | 2,723,509 | $2.4M | 1.04% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 93,414 | $2.0M | 0.88% |
| 9 | LAVA THERAPEUTICS NV | N51517105 | 1,149,345 | $1.8M | 0.79% |
| 10 | XILIO THERAPEUTICS INC | XLO | 1,483,758 | $1.3M | 0.55% |
| 11 | CARISMA THERAPEUTICS INC | CARM | 1,473,240 | $403,668 | 0.18% |
| 12 | NEUPHORIA THERAPEUTICS INC | NEUP | 10,027 | $118,218 | 0.05% |
| 13 | TUHURA BIOSCIENCES | HURA | 13,950 | $34,596 | 0.02% |